State Of New Jersey Common Pension Fund D Affimed N.V. Transaction History

State Of New Jersey Common Pension Fund D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$7.78 - $11.4 $158,393 - $232,092	-20,359 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$5.12 - $8.48 $104,238 - $172,644	20,359 New	20,359 $161,000
Q3 2020 Oct 27, 2020	SELL	$3.26 - $4.73 $33,004 - $47,886	-10,124 Closed	0 $0
Q2 2019 Jul 22, 2019	BUY	$2.6 - $4.21 $26,322 - $42,622	10,124 New	10,124 $29,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.